When QoL was investigated in the 2014 PD-MED study, it was found that early initiation of levodopa resulted in a better QoL on the long term than initiating dopamine agonists and MAO-B inhibitors (PD MED Collaborative Group, 2014). The gene discussed is MAOB; the disease is Parkinson disease.